Berger Mark Stanley 4
4 · Actinium Pharmaceuticals, Inc. · Filed Jul 17, 2018
Insider Transaction Report
Form 4
Berger Mark Stanley
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2018-07-13$0.78/sh+250,000$195,725→ 250,000 totalExercise: $0.78From: 2018-07-13Exp: 2028-07-13→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant.